May 28, 2013

Pharmacy Intelligence applies application-based data analytics, computer-animated graphic process simulation and Lean Six Sigma principles to enable a new level of more advanced modeling and forecasting.

January 9, 2013

Generic drug maker Watson Pharmaceuticals has hired a former executive from the Generic Pharmaceutical Association to head lobbying at the federal and state level, the company said.

November 13, 2012

Towers Watson on Tuesday announced that it has selected Loblaw Companies as the preferred pharmacy services provider for its Towers Watson Canadian Rx Coalition, a collaborative network of private sector drug plan sponsors.

November 1, 2012

Watson Pharmaceuticals is changing its name to Actavis following its acquisition of the Swiss drug maker, Watson said.

October 8, 2012

European regulators have approved U.S. drug maker Watson's acquisition of Switzerland-based Actavis, Watson said.

June 28, 2012

Mylan is challenging the patent protection on a Pfizer drug for treating depression, following an announcement of a similar challenge by Watson made earlier this week.

May 16, 2012

Watson has announced its intention to acquire Actavis, the company said. Following news reports that the U.S.-based generic drug maker would acquire Switzerland-based Actavis, Watson announced that it would buy the latter for $5.6 billion.

April 26, 2012

Watson has announced its intention to acquire Actavis, the company said.

April 3, 2012

Watson is challenging the patent protection on two eye drugs made by Allergan, the generic drug maker said Tuesday.

September 12, 2011

Healthcare giant WellPoint has inked a deal with IBM whereby it will develop applications using IBM's Watson artificial intelligence technology to deliver healthcare information to patients.

September 12, 2011

At press time, Hurricane Irene was slowly barreling toward the East Coast and threatening the area with a deluge that prompted cities to shut down and had store shelves wiped clean.


March 25, 2011

A generic painkiller made by Watson Pharmaceuticals infringes a patent covering the branded version, a U.S. District Court ruled.

March 9, 2011

Generic drug maker Watson Pharmaceuticals has promoted two executives to EVP, the company said Wednesday.

May 31, 2010

Columbia Labs is seeking shareholder approval for an agreement in which Watson would acquire the...

March 9, 2010

MORRISTOWN, N.J. Watson Pharmaceuticals and Takeda Pharmaceuticals North America have settled a patent litigation case...

March 8, 2010

Watson Pharmaceuticals has filed a regulatory approval application for a generic version of a painkiller...

January 31, 2010

Watson Pharmaceuticals and HRA Pharma have signed a deal whereby Watson will become the commercial...